Veritas Farms Inc
Veritas Farms, Inc. focuses on growing, producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids. The company's products include capsules, gummies, tinctures, lotions, salves, cream, balm sticks, lip balms, and pet chews. It markets and sells its products under the Veritas Farms brand name, as well as through bulk, white label and private label custom formulation… Read more
Veritas Farms Inc (VFRM) - Net Assets
Latest net assets as of September 2023: $207.46K USD
Based on the latest financial reports, Veritas Farms Inc (VFRM) has net assets worth $207.46K USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.32 Million) and total liabilities ($8.11 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $207.46K |
| % of Total Assets | 2.49% |
| Annual Growth Rate | N/A |
| 5-Year Change | -109.97% |
| 10-Year Change | N/A |
| Growth Volatility | 83.26 |
Veritas Farms Inc - Net Assets Trend (2015–2022)
This chart illustrates how Veritas Farms Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Veritas Farms Inc (2015–2022)
The table below shows the annual net assets of Veritas Farms Inc from 2015 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-606.28K | -112.56% |
| 2021-12-31 | $4.83 Million | -36.90% |
| 2020-12-31 | $7.65 Million | -37.29% |
| 2019-12-31 | $12.20 Million | +100.60% |
| 2018-12-31 | $6.08 Million | +95.59% |
| 2017-12-31 | $3.11 Million | +6032.41% |
| 2016-12-31 | $-52.40K | +16.41% |
| 2015-12-31 | $-62.68K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Veritas Farms Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3941462200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $41.62K | % |
| Other Components | $38.83 Million | % |
| Total Equity | $-606.28K | 100.00% |
Veritas Farms Inc Competitors by Market Cap
The table below lists competitors of Veritas Farms Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SIMH3F
SA:SIMH3F
|
$16.40K |
|
Eleving Group S.A.
XETRA:OT8
|
$16.42K |
|
Hello Pal International Inc
PINK:HLLPF
|
$16.42K |
|
SONAE R
BE:YSON
|
$16.43K |
|
Cubox Co. Ltd.
KO:340810
|
$16.38K |
|
Senhwa Biosciences, Inc.
TWO:6492
|
$16.38K |
|
NTCO3F
SA:NTCO3F
|
$16.37K |
|
GreenOak Spain Holdings SOCIMI S.A.
MC:YGO2
|
$16.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Veritas Farms Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 4,825,285 to -606,277, a change of -5,431,562 (-112.6%).
- Net loss of 5,143,908 reduced equity.
- Other factors decreased equity by 287,654.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.14 Million | -848.44% |
| Other Changes | $-287.65K | -47.45% |
| Total Change | $- | -112.56% |
Book Value vs Market Value Analysis
This analysis compares Veritas Farms Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $-0.01 | $0.00 | x |
| 2015-12-31 | $0.00 | $0.00 | x |
| 2016-12-31 | $0.00 | $0.00 | x |
| 2017-12-31 | $0.21 | $0.00 | x |
| 2018-12-31 | $0.31 | $0.00 | x |
| 2019-12-31 | $0.35 | $0.00 | x |
| 2020-12-31 | $0.18 | $0.00 | x |
| 2021-12-31 | $0.11 | $0.00 | x |
| 2022-12-31 | $-0.01 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Veritas Farms Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -483.86%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-60.43%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-195.90 |
| 2016 | 0.00% | -57.34% | 6.03x | 0.00x | $-38.47K |
| 2017 | -78.95% | -220.15% | 0.21x | 1.68x | $-2.76 Million |
| 2018 | -63.10% | -184.42% | 0.30x | 1.15x | $-4.44 Million |
| 2019 | -91.56% | -153.13% | 0.51x | 1.17x | $-12.39 Million |
| 2020 | -99.28% | -121.95% | 0.50x | 1.62x | $-8.36 Million |
| 2021 | -150.53% | -235.69% | 0.36x | 1.78x | $-7.75 Million |
| 2022 | 0.00% | -483.86% | 0.16x | 0.00x | $-5.08 Million |
Industry Comparison
This section compares Veritas Farms Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Veritas Farms Inc (VFRM) | $207.46K | 0.00% | 39.10x | $16.39K |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |